• Home
  • Medical Policy Update

Medical Policy Update

Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on our website on February 1, 2024.

Effective 03/01/24:

  • Hemophilia A Gene Therapy Medical Drug Criteria Program Summary

To view these medical policies, please visit our Medical Policy page of our website, https://www.bcbsks.com/providers/medical-policies

Pharmacy Medical Policy Update

The following Pharmacy Medical Policy programs have been updated February 1, 2024:

Effective 03/01/24:

  • Biologic Immunomodulators
  • IL-1 Inhibitors
  • Cibinqo
  • IL-4 Inhibitor
  • IL-5 Inhibitors
  • Tezspire
  • Xolair
  • Lupus
  • Opzelura
  • Weight Loss Agents
  • Statin

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.

If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.

Institutional Providers
Professional Providers